Janus Henderson Group’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,188
Closed -$194K 2591
2023
Q3
$194K Hold
1,188
﹤0.01% 2394
2023
Q2
$389K Sell
1,188
-2
-0.2% -$610 ﹤0.01% 2121
2023
Q1
$328K Buy
1,190
+660
+125% +$242K ﹤0.01% 2242
2022
Q4
$205K Buy
+530
New +$149K ﹤0.01% 2174
2022
Q2
Sell
-530
Closed -$360K 2655
2022
Q1
$360K Buy
530
+1
+0.2% +$602 ﹤0.01% 2109
2021
Q4
$366K Buy
+529
New +$391K ﹤0.01% 2088
2021
Q2
Sell
-5,347
Closed -$4.36M 1652
2021
Q1
$4.36M Sell
5,347
-2,293
-30% -$1.77M ﹤0.01% 1033
2020
Q4
$6.51M Buy
7,640
+463
+6% +$357K ﹤0.01% 921
2020
Q3
$5.38M Buy
+7,177
New +$5.89M ﹤0.01% 914

Other funds holding OM

Janus Henderson Group's OM Position: Q4 2023 in Review

Janus Henderson Group sold out of Outset Medical (OM) in Q4 2023, closing a stake of 1,188 shares — an estimated $194K sold.

Janus Henderson Group first reported a position in OM in Q3 2020 and held it in 9 quarters. The position peaked at $6.51M in Q4 2020. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Janus Henderson Group reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 1,188 Outset Medical shares in Q4 2023, an estimated $194K.
  • Janus Henderson Group first reported a position in Outset Medical in Q3 2020 and held it in 9 quarters.
  • Janus Henderson Group's Outset Medical position peaked at $6.51M in Q4 2020.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.